MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,296,935
Free Cash flow
$2,083,466
Unit: Dollar
Positive Cash Flow Breakdown
Net income
Bad debt expense
Accrued liabilities
Others
Negative Cash Flow Breakdown
Issuance of note receivable
Common stock buyback/retirement
Accounts receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Gain on termination of operating lease
-
-
-
12,262
Net income
1,985,635
1,686,040
1,819,529
6,978,127
Depreciation and amortization
95,414
223,930
243,746
1,251,514
Amortization of operating right of use asset
0
0
0
63,597
Stock compensation expense
70,013
156,033
101,023
403,783
Bad debt expense
225,000
225,000
225,000
600,000
Accounts receivables
445,070
978,753
245,439
1,301,304
Operating right of use asset
-
-
-
-186,709
Long-term receivables, prepaids and other assets
236,503
260,726
265,761
447,479
Accounts payable
80,949
-120,400
27,480
17,060
Operating lease liability
0
0
0
-250,786
Accrued liabilities
199,798
346,778
122,580
196,499
Deferred revenue
108,230
960,323
-489,711
734,674
Net cash provided by operating activities
2,083,466
2,238,225
1,538,447
8,420,132
Issuance of note receivable
3,000,000
-
-
-
Purchase of property and equipment
0
-1
11,750
15,965
Sale (purchase) of marketable securities
-31,328
20
-8,609
16,134
Net cash provided by (used in) investing activities
-3,031,328
21
-20,359
169
Common stock buyback/retirement
549,944
1,098,608
149,985
200,035
Redemption of series b-1 preferred
-
-
-
2,999,970
Redemption of series b preferred
375,003
749,995
749,995
-
Proceeds from exercise of warrants
0
0
-
79,120
Proceeds from employee stock plan
41,040
0
63,479
134,346
Dividends paid
410,785
424,495
402,917
1,656,377
Payments on notes payable and capital leases
54,381
53,461
52,669
362,442
Net cash used in financing activities
-1,349,073
-2,326,559
-1,292,087
-5,005,358
Net increase (decrease) in cash and cash equivalents
-2,296,935
-88,313
226,001
3,414,943
Cash and cash equivalents at beginning of period
28,794,806
28,794,806
28,568,805
25,153,862
Cash and cash equivalents at end of period
26,409,558
28,706,493
28,794,806
28,568,805
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,985,635
Bad debt expense
$225,000
Accrued liabilities
$199,798
Deferred revenue
$108,230
Depreciation and
amortization
$95,414
Accounts payable
$80,949
Stock compensation
expense
$70,013
Net cash provided by
operating activities
$2,083,466
Canceled cashflow
$681,573
Net increase
(decrease) in cash and cash...
-$2,296,935
Canceled cashflow
$2,083,466
Proceeds from employee
stock plan
$41,040
Accounts receivables
$445,070
Long-term receivables,
prepaids and other assets
$236,503
Net cash provided by
(used in) investing...
-$3,031,328
Net cash used in
financing activities
-$1,349,073
Canceled cashflow
$41,040
Issuance of note
receivable
$3,000,000
Sale (purchase) of
marketable securities
-$31,328
Common stock
buyback/retirement
$549,944
Dividends paid
$410,785
Redemption of series b
preferred
$375,003
Payments on notes payable
and capital leases
$54,381
Buy us a coffee
ReposiTrak, Inc. (TRAK)
ReposiTrak, Inc. (TRAK)